Repeated BCG treatment of mouse bladder selectively stimulates small GTPases and HLA antigens and inhibits single-spanning uroplakins
2007

Effects of Repeated BCG Treatment on Mouse Bladder

Sample size: 60 publication Evidence: moderate

Author Information

Author(s): Saban Marcia R, Hellmich Helen L, Simpson Cindy, Davis Carole A, Lang Mark L, Ihnat Michael A, O'Donnell Michael A, Wu Xue-Ru, Saban Ricardo

Primary Institution: The University Oklahoma Health Sciences Center

Hypothesis

Does repeated intravesical BCG therapy alter gene expression in the mouse bladder?

Conclusion

Repeated BCG treatment up-regulates genes related to antigen presentation and small GTPases while down-regulating certain uroplakins.

Supporting Evidence

  • BCG treatment increased expression of genes related to immune response.
  • Small GTPases were significantly up-regulated after BCG treatment.
  • Uroplakins were down-regulated in response to BCG therapy.
  • Chronic BCG treatment led to a unique cytokine release profile.
  • Gene expression changes were validated using ChIP/Q-PCR.

Takeaway

When mice get BCG treatment for their bladders, it helps their immune system recognize and fight off infections better, but it also changes some of the bladder's normal proteins.

Methodology

Mice were treated with BCG or saline, and gene expression was analyzed using suppression subtractive hybridization and ChIP/Q-PCR.

Limitations

The study's findings are based on a single time point and may not capture the full dynamics of the immune response over time.

Participant Demographics

C57BL/6 female mice, aged 10 to 12 weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2407-7-204

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication